橋連整合因子蛋白抗體 返回列表頁

英文名稱 BIN1
中文名稱 橋連整合因子蛋白抗體
別    名 Amphiphysin like protein; AMPH 2; AMPH2; Amphiphysin 2; Amphiphysin II; Amphiphysin like protein; amphiphysin-like; AMPHL; Box Dependant MYC Interacting Protein 1; Bridging Integrator 1; DKFZp547F068; MGC10367; MGC105358; Myc box dependent interacting protein 1; SH3P9; BIN1_HUMAN.
橋連整合因子蛋白抗體

說 明 書 0.1ml  0.2ml  
研究領(lǐng)域 腫瘤  免疫學(xué)  
抗體來源 Rabbit
克隆類型 Polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Cow, Horse, 
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量 65kDa
性    狀 Lyophilized or Liquid
濃    度 1mg/1ml
免 疫 原 KLH conjugated synthetic peptide derived from human BIN1
亞    型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.

產(chǎn)品介紹 background:
The identification and analysis of tumor suppressors is of major importance for improved diagnosis and treatment of tumors. Bin1 (Box-dependent myc interacting protein 1, also known as SH3P9, amphiphysin II and amphl/amphiphysin-like) is a novel protein that has features of a tumor suppressor. Bin1 interacts with and inhibits the oncogenic activity of the myc oncoprotein that has a major role in many human cancers. The loss of Bin1 may contribute to growth deregulation in cancer cells in carcinoma of the breast, colon, lung, cervix, prostate and liver. Bin1 also interacts with HCV NS5A through its SH3 domain.

Function:
May be involved in regulation of synaptic vesicle endocytosis. May act as a tumor suppressor and inhibits malignant cell transformation.

Subunit:
Heterodimer with AMPH. Binds SH3GLB1 (By similarity). Interacts (via SH3 domain) with SYNJ1. Interacts (via SH3 domain) with DNM1. Isoform IIA interacts with CLTC. Isoform IIB does not interact with CLTC. Isoform IIC1 does not interact with CLTC. Isoform IIC2 does not interact with CLTC. Interacts with AP2A2. Interacts with AP2B1. Interacts with MYC (via N-terminal transactivation domain); the interaction requires the integrity of the conserved MYC box regions 1 and 2. Interacts with BIN2. Interacts (SH3 domain) with HCV NS5A.

Subcellular Location:
Isoform BIN1: Nucleus.
Isoform IIA: Cytoplasm.

Tissue Specificity:
Ubiquitous. Highest expression in the brain and muscle. Isoform IIA is expressed only in the brain where it is concentrated in axon initial segments and nodes of Ranvier. Isoform BIN1 is widely expressed with highest expression in skeletal muscle.

Post-translational modifications:
Phosphorylated by protein kinase C.

DISEASE:
Myopathy, centronuclear, 2 (CNM2) [MIM:255200]: A congenital muscle disorder characterized by progressive muscular weakness and wasting involving mainly limb girdle, trunk, and neck muscles. It may also affect distal muscles. Weakness may be present during childhood or adolescence or may not become evident until the third decade of life. Ptosis is a frequent clinical feature. The most prominent histopathologic features include high frequency of centrally located nuclei in muscle fibers not secondary to regeneration, radial arrangement of sarcoplasmic strands around the central nuclei, and predominance and hypotrophy of type 1 fibers. Note=The disease is caused by mutations affecting the gene represented in this entry.

Similarity:
Contains 1 BAR domain.
Contains 1 SH3 domain.

Gene ID:
274

Database links:

Entrez Gene: 274 Human

Entrez Gene: 30948 Mouse

Entrez Gene: 117028 Rat

Omim: 601248 Human

SwissProt: O00499 Human

SwissProt: O08539 Mouse

SwissProt: O08839 Rat

Unigene: 193163 Human

Unigene: 4383 Mouse

Unigene: 17098 Rat
xy-4007R ATG16L自噬相關(guān)蛋白16A抗體
xy-5201R phospho-ATG4D(Ser15)磷酸化自噬相關(guān)蛋白4D抗體
xy-5196R Phospho-ATG4C(Ser451)磷酸化自噬相關(guān)蛋白4C抗體
xy-5197R phospho-ATG7(Ser95)磷酸化自噬相關(guān)蛋白7抗體
xy-5198R phospho-ATG16A(Ser287)磷酸化自噬相關(guān)蛋白16A抗體
xy-5199R phospho-ATG9A(Ser735)磷酸化自噬相關(guān)蛋白9A抗體
xy-5202R phospho-ATG4D(Ser341)磷酸化自噬相關(guān)蛋白4D抗體
xy-5203R phospho-ATG4D(Ser467)磷酸化自噬相關(guān)蛋白4D抗體
xy-5210R phospho-TEM8 (Tyr382)磷酸化腫瘤血管內(nèi)皮標(biāo)志物8抗體
xy-5207R phospho-ATG4A(Ser100)磷酸化自噬相關(guān)蛋白4A抗體
xy-5208R phospho-ATG4C(Ser166)磷酸化自噬相關(guān)蛋白4C抗體
xy-5206R phospho-ATG16A(Ser213)磷酸化自噬相關(guān)蛋白16A抗體
xy-5209R phospho-AKT3 (Ser472)磷酸化蛋白激酶AKT3抗體
xy-5211R phospho-ADRB2 (Ser261)磷酸化腎上腺素能受體β2抗體
xy-5214R phospho-AQP2(Ser261)磷酸化水通道蛋白2抗體
xy-5204R phospho-ATG3 (Tyr18)磷酸化自噬相關(guān)蛋白3抗體
xy-4026R ALDOB醛縮酶2抗體
xy-3975R AMY2A胰腺α淀粉酶抗體
xy-7961R ANKRD11錨蛋白重復(fù)結(jié)構(gòu)域蛋白11抗體
xy-8440R phospho-c-ABL1+2 (Tyr393+429)磷酸化非受體酪氨酸激酶c-Abl抗體
xy-8449R phospho-ATF2 (Thr53)磷酸化活化復(fù)制因子2抗體
xy-5026R AKR1D1醛固酮還原酶家族1成員D1抗體
xy-5027R ARP4肝血管生成素相關(guān)蛋白抗體
xy-5028R ABHD5自水解酶結(jié)構(gòu)域5蛋白抗體
xy-5031R ACOT8?；o酶A硫酯酶8